The role of cytoreductive nephrectomy in metastatic renal cell carcinoma in the modern era

被引：0
|
作者：
Fortuna, Gliceida M. Galarza [1 ]
Maughan, Benjamin L. [1 ]
机构：
[1] Univ Utah, Huntsman Canc Inst, Div Med Oncol, 2000 Circle of Hope,Ste 2123, Salt Lake City, UT 84112 USA
来源：
TRANSLATIONAL ANDROLOGY AND UROLOGY | 2024年 / 13卷 / 05期
关键词：
Renal cell carcinoma (RCC); tyrosine kinase inhibitor (TKI); cytoreductive nephrectomy (CN); immune checkpoint inhibitor (ICI); INTERFERON-ALPHA; SUNITINIB; SURVIVAL; CANCER; IMPACT;
D O I：
10.21037/tau-23-646
中图分类号：
R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：915 / 919
页数：5
相关论文
共 50 条
  • [31] Cytoreductive Nephrectomy in Elderly Patients with Metastatic Renal Cell Carcinoma in the Targeted Therapy Era
    Uprety, Dipesh
    Bista, Amir
    Smith, Angela L.
    Vallatharasu, Yazhini
    Marinier, David E.
    ANTICANCER RESEARCH, 2018, 38 (05) : 3013 - 3018
  • [32] Cytoreductive nephrectomy in advanced or metastatic renal cell carcinoma (mRCC): In the era of targeted strategies
    Toutziaris, C.
    Lontovinis, L.
    Tsoukalas, N.
    Radopoulos, D.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2011, 78 : S26 - S26
  • [33] Role of cytoreductive nephrectomy in renal cell carcinoma
    Chiong, Edmund
    Wood, Christopher G.
    Margulis, Vitaly
    FUTURE ONCOLOGY, 2009, 5 (06) : 859 - 869
  • [34] Partial cytoreductive nephrectomy versus cytoreductive nephrectomy in metastatic renal cell carcinoma.
    Vitruk, Iurly
    Stakhovskyi, Oleksandr
    Voylenko, Oleg
    Kotov, Volodymyr
    Pikul, Maxim
    Stakhovsky, Eduard
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [35] Role of Cytoreductive Nephrectomy in Metastatic Clear Cell Renal cell Carcinoma in the Era of immunotherapy: An Analysis of the National Cancer Database
    Zerdan, Maroun Bou
    Niforatos, Stephanie
    Arunachalam, Swathi
    Jamaspishvili, Tamara
    Wong, Roger
    Bratslavsky, Gennady
    Jacob, Joseph
    Ross, Jeffrey
    Shapiro, Oleg
    Goldberg, Hanan
    Basnet, Alina
    CLINICAL GENITOURINARY CANCER, 2024, 22 (06)
  • [36] IS THERE A ROLE FOR NEPHRON SPARING CYTOREDUCTIVE PARTIAL NEPHRECTOMY IN METASTATIC RENAL CELL CARCINOMA?
    Hockman, Lukas
    McGuffey, Logan
    Dwan, Aaron
    Pokala, Naveen
    JOURNAL OF UROLOGY, 2018, 199 (04): : E782 - E782
  • [37] The independent oncological role for cytoreductive nephrectomy in metastatic renal cell carcinoma: Prognostic features in the era of targeted therapies
    Claeys, Tom
    Lumen, Nicolaas
    Kumps, Candy
    Praet, Marleen
    De Meerleer, Gert
    Rottey, Sylvie
    Ost, Piet
    Devisschere, Pieter
    Villeirs, Geert
    Fonteyne, Valerie
    Decaestecker, Karel
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2017, 35 (04) : 152.e13 - 152.e22
  • [38] Evolving role of cytoreductive nephrectomy in metastatic renal cell carcinoma of variant histology
    Alhalabi, Omar
    Karam, Jose A.
    Tannir, Nizar M.
    CURRENT OPINION IN UROLOGY, 2019, 29 (05) : 521 - 525
  • [39] Is it time to reconsider the role of upfront cytoreductive nephrectomy in metastatic renal cell carcinoma?
    Braun, Avery E.
    Meng, Maxwell, V
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2024, 116 (07): : 1002 - 1004
  • [40] Cytoreductive nephrectomy in patients with metastatic renal cell carcinoma in the era of targeted therapy: a bibliographic review
    Rodriguez Faba, Oscar
    Brookman-May, Sabine D.
    Linares, Estefania
    Breda, Alberto
    Pisano, Francesca
    Daniel Subiela, Jose
    Sanguedolce, Francesco
    Brausi, Maurizio
    Palou, Joan
    WORLD JOURNAL OF UROLOGY, 2017, 35 (12) : 1807 - 1816
12345